Internist (infectious diseases and acute medicine)

Amsterdam UMC, Amsterdam, the Netherlands

Edgar J.G. Peters (Heerenveen, Friesland, The Netherlands) started medical school at VU University Medical Center, Amsterdam, The Netherlands in 1993. He has worked in 1997 and 1998 as a researcher at the University of Texas Health Science Center in San Antonio, Texas, USA. He graduated medical school of VU University Medical Center in Amsterdam in 2000 cum laude. In 2002, he finished a PhD thesis on diabetic foot complications and started a traineeship internal medicine at Leiden University Medical Center in Leiden, The Netherlands. He registered as an internist in 2007. He is also dually registered in both Infectious Diseases and Acute Medicine. He currently works as Internist, Infectious Diseases and Acute Medicine Specialist at Amsterdam University Medical Centers, location VUmc, where he is the director of the Infectious Diseases Fellowship Program. His  main research interest is infections of the musculoskeletal system, especially diabetic foot infections and bone infection. Recent research projects were to the microbiome of diabetic foot bone infection (osteomyelitis), monitoring treatment of osteomyelitis with biomarkers, cold atmospheric plasma treatment of diabetic foot ulcers, and diagnostic strategies for diabetic foot osteomyelitis. He has combined diabetic foot research with research to other musculoskeletal infections, e.g., prosthetic joint prosthesis associated infection. He has also been involved in writing guidelines for treatment of diabetic foot complications for the Infectious Diseases Society of America, the Wound Healing Society, the European Wound Management Association, the International Working Group on the Diabetic Foot and the Dutch Internist Society (NIV). He also chairs the Dutch guideline committee for prosthetic joint associated infections. He is the Scientific Secretary of the International Symposium on the Diabetic Foot. Edgar Peters has authored over 100 journal articles and books chapters.

Full disclosure of interest available here »